A Respiratory Therapist-Directed Protocol for Managing Inpatients with Asthma and COPD Incorporating a Long-Acting Bronchodilator
Authors:
- 1 January 2005
- journal article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 42 (1) , 29-34
Abstract
This prospective study was designed to determine whether incorporating formoterol into a standardized respiratory therapist-directed protocol for administering bronchodilators to hospitalized patie...Keywords
This publication has 28 references indexed in Scilit:
- Comparison of the Effects of Salmeterol and Formoterol in Patients With Severe AsthmaChest, 2002
- Safety of formoterol Turbuhaler® at cumulative dose of 90 µg in patients with acute bronchial obstructionEuropean Respiratory Journal, 2001
- Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthmaThe American Journal of Medicine, 1999
- The long‐acting β2‐agonist salmeterol xinafoate: effects on airway inflammation in asthmaEuropean Respiratory Journal, 1999
- Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severityJournal of Allergy and Clinical Immunology, 1999
- Clinical Experience over Five Years of Daily Therapy with Formoterol in Patients with Bronchial AsthmaClinical Drug Investigation, 1997
- Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of actionEuropean Respiratory Journal, 1996
- A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patientsEuropean Respiratory Journal, 1996
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate AsthmaNew England Journal of Medicine, 1992